This is the bio for Patricia Van Arnum, senior editor of Pharmaceutical Technology magazine.
Patricia Van Arnum
Executive Editor
732.346.3072, pvanarnum@advanstar.com
Patricia Van Arnum, executive editor, covers active pharmaceutical ingredients (APIs), intermediates, fine chemicals, advances in process R&D, formulation development, and finished drug-product manufacturing for Pharmaceutical Technology. She also is editor of Sourcing and Management, a monthly newsletter of Pharmaceutical Technology covering sourcing, the pharmaceutical supply-chain, API synthesis and manufacturing, and formulation development and finished drug-product manufacturing. Patricia has 20 years of experience as a business and science journalist and editor, which includes 17 years of experience covering the pharmaceutical and fine-chemicals industries. Patricia was formerly executive editor of Chemical Market Reporter (now ICIS Chemical Business) and was with CMR and ICIS from 1995–2005. She joined Pharmaceutical Technology as a senior editor in January 2006. She holds undergraduate degrees in chemistry, economics, and political science. She is a member of the American Chemical Society, the American Association of Pharmaceutical Scientists, the American Medical Writers Association, and the American Association for the Advancement of Science.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.